Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Semaglutide effects on cardiovascular outcomes in people with overweight or obesity

Clinical Trial Grant
Duke Scholars

Administered By

Duke Molecular Physiology Institute

Awarded By

Novo Nordisk, Inc.

Start Date

March 22, 2019

End Date

March 31, 2023
 

Administered By

Duke Molecular Physiology Institute

Awarded By

Novo Nordisk, Inc.

Start Date

March 22, 2019

End Date

March 31, 2023